Abstract:Gene expression involves transcription and translation. Despite large datasets and increasingly powerful methods devoted to calculating genetic variants’ effects on transcription, discrepancy between messenger RNA and protein levels hinders the systematic interpretation of the regulatory effects of disease-associated variants. Accurate models of the sequence determinants of translation are needed to close this gap and to interpret disease-associated variants that act on translation. Here we present Translatomer, a multimodal transformer framework that predicts cell-type-specific translation from messenger RNA expression and gene sequence. We train the Translatomer on 33 tissues and cell lines, and show that the inclusion of sequence improves the prediction of ribosome profiling signal, indicating that the Translatomer captures sequence-dependent translational regulatory information. The Translatomer achieves accuracies of 0.72 to 0.80 for the de novo prediction of cell-type-specific ribosome profiling. We develop an in silico mutagenesis tool to estimate mutational effects on translation and demonstrate that variants associated with translation regulation are evolutionarily constrained, both in the human population and across species. In particular, we identify cell-type-specific translational regulatory mechanisms independent of the expression quantitative trait loci for 3,041 non-coding and synonymous variants associated with complex diseases, including Alzheimer’s disease, schizophrenia and congenital heart disease. The Translatomer accurately models the genetic underpinnings of translation, bridging the gap between messenger RNA and protein levels as well as providing valuable mechanistic insights for uninterpreted disease variants. A transformer-based approach called Translatomer is presented, which models cell-type-specific translation from messenger RNA expression and gene sequence, bridging the gap between messenger RNA and protein levels as well as providing a mechanistic insight into the genetic regulation of translation.

Block-level refinement of motion description in layered H.261 video

ML-driven design of 3’ UTRs for mRNA stability

Human 5′ UTR design and variant effect prediction from a massively parallel translation assay

A novel deep generative model for mRNA vaccine development: Designing 5ʹ UTRs with N 1-methyl-pseudouridine modification

Scalable Differentiable for mRNA Design

Integrated mRNA sequence optimization using deep learning

Hydrophobic Optimization of Functional Poly(TPAE-co-suberoyl chloride) for Extrahepatic mRNA Delivery following Intravenous Administration

Joint Design of 5' Untranslated Region and Coding Sequence of mRNA

Rational Design of Untranslated Regions to Enhance Gene Expression

High-throughput 5′ UTR engineering for enhanced protein production in non-viral gene therapies

A Novel Engineered U7 Small Nuclear RNA Scaffold Greatly Increases and ADAR-Mediated Programmable RNA Base Editing

UTRGAN: Learning to Generate 5′ UTR Sequences for Optimized Translation Efficiency and Gene Expression

Deep Generative Optimization of mRNA Codon Sequences for Enhanced Protein Production and Therapeutic Efficacy

Deep Learning Prediction of Ribosome Profiling with Translatomer Reveals Translational Regulation and Interprets Disease Variants

When Mrna Meets Gene Editing

Expression of Single mRNA Constructs Encoding Both CRISPR-Cas9 Protein and Guide RNAs for Future Gene Therapy Applications

Generative machine learning of ADAR substrates for precise and efficient RNA editing

Quantitative profiling of human translation initiation reveals regulatory elements that potently affect endogenous and therapeutically modified mRNAs

A 5' UTR Language Model for Decoding Untranslated Regions of mRNA and Function Predictions

Optimization of C-to-G base editors with sequence context preference predictable by machine learning methods

Augmented translation via multitailed mRNA